Northeast Investment Management Johnson & Johnson Transaction History

Northeast Investment Management

$2.08 Billion
Q2 2024

A detailed history of Northeast Investment Management transactions in Johnson & Johnson stock. As of the latest transaction made, Northeast Investment Management holds 189,617 shares of JNJ stock, worth $31.5 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares

189,617

Previous 195,989 3.25%

Holding current value

$31.5 Million

Previous $31 Million 10.61%

% of portfolio

1.33%

Previous 1.56%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$144.38 - $157.78 $919,989 - $1.01 Million	-6,372 Reduced 3.25%	189,617 $27.7 Million
Q1 2024 May 01, 2024	SELL	$155.22 - $162.74 $144,044 - $151,022	-928 Reduced 0.47%	195,989 $31 Million
Q4 2023 Feb 09, 2024	SELL	$145.6 - $158.88 $275,329 - $300,442	-1,891 Reduced 0.95%	196,917 $30.9 Million
Q3 2023 Nov 08, 2023	SELL	$155.75 - $174.48 $2.39 Million - $2.68 Million	-15,342 Reduced 7.16%	198,808 $31 Million
Q2 2023 Jul 28, 2023	SELL	$154.35 - $166.11 $618,326 - $665,436	-4,006 Reduced 1.84%	214,150 $35.4 Million
Q1 2023 Apr 28, 2023	SELL	$151.05 - $180.26 $437,138 - $521,672	-2,894 Reduced 1.31%	218,156 $33.8 Million
Q4 2022 Jan 27, 2023	SELL	$160.2 - $179.79 $422,447 - $474,106	-2,637 Reduced 1.18%	221,050 $39 Million
Q3 2022 Oct 28, 2022	SELL	$161.33 - $179.52 $359,443 - $399,970	-2,228 Reduced 0.99%	223,687 $36.5 Million
Q2 2022 Aug 05, 2022	BUY	$168.19 - $186.01 $193,754 - $214,283	1,152 Added 0.51%	225,915 $40.1 Million
Q1 2022 May 04, 2022	BUY	$158.14 - $179.59 $244,326 - $277,466	1,545 Added 0.69%	224,763 $39.8 Million
Q4 2021 Feb 07, 2022	SELL	$155.93 - $173.01 $514,413 - $570,759	-3,299 Reduced 1.46%	223,218 $38.2 Million
Q3 2021 Nov 08, 2021	BUY	$161.5 - $179.47 $321,708 - $357,504	1,992 Added 0.89%	226,517 $36.6 Million
Q2 2021 Aug 05, 2021	SELL	$159.48 - $171.07 $189,143 - $202,889	-1,186 Reduced 0.53%	224,525 $37 Million
Q1 2021 May 11, 2021	BUY	$153.07 - $170.48 $87,556 - $97,514	572 Added 0.25%	225,711 $37.1 Million
Q4 2020 Feb 10, 2021	BUY	$137.11 - $157.38 $7,266 - $8,341	53 Added 0.02%	225,139 $35.4 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $336,350 - $368,576	2,396 Added 1.08%	225,086 $33.5 Million
Q2 2020 Aug 11, 2020	BUY	$128.81 - $155.51 $290,981 - $351,297	2,259 Added 1.02%	222,690 $31.3 Million
Q1 2020 May 13, 2020	SELL	$111.14 - $153.99 $762,976 - $1.06 Million	-6,865 Reduced 3.02%	220,431 $28.9 Million
Q4 2019 Feb 12, 2020	SELL	$127.5 - $146.44 $555,262 - $637,746	-4,355 Reduced 1.88%	227,296 $33.2 Million
Q3 2019 Nov 13, 2019	SELL	$126.95 - $142.14 $842,694 - $943,525	-6,638 Reduced 2.79%	231,651 $30 Million
Q2 2019 Aug 12, 2019	BUY	$131.15 - $144.24 $371,679 - $408,776	2,834 Added 1.2%	238,289 $33.2 Million
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $126,725 - $140,908	-1,008 Reduced 0.43%	235,455 $32.9 Million
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $502,538 - $604,813	-4,091 Reduced 1.7%	236,463 $30.5 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $558,295 - $656,104	-4,592 Reduced 1.87%	240,554 $33.2 Million
Q2 2018 Aug 13, 2018	SELL	$119.4 - $131.76 $210,621 - $232,424	-1,764 Reduced 0.71%	245,146 $29.7 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $318,879 - $377,608	-2,549 Reduced 1.02%	246,910 $31.6 Million
Q4 2017 Jan 29, 2018	SELL	$131.22 - $143.62 $449,034 - $491,467	-3,422 Reduced 1.35%	249,459 $34.9 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $32.7 Million - $34.2 Million	252,881	252,881 $32.9 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Investment Management with notifications on news.

Account

Northeast Investment Management Johnson & Johnson Transaction History